Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 82
  • Journal CiteScore: 35.06
  • Journal Impact Factor: 24.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Julia Alvarez Fallas

Department of Endocrinology, Zoological Institute and Museum, Germany

Publications
  • Expert Review   
    Clinicopathologic Features and Therapeutic Strategies of this Tumor of the Pancreas
    Author(s): Julia Alvarez Fallas*

    Pancreatic neuroendocrine tumours (NETs) can be benign or cancerous (cancer). When pancreatic NETs become cancerous, they are referred to as pancreatic endocrine cancer or islet cell carcinoma. Pancreatic NETs are substantially less prevalent and have a better prognosis than pancreatic exocrine tumours. Pancreatic cancer is frequently discovered after it has progressed. As a result, it is one of the main causes of cancer mortality. The pancreatic cancer survival rate after one year is higher. After five years, that rate reduces to around 6%. Some pancreatic growths are merely benign (not cancerous), while others, if left untreated, may develop into cancer over time (known as pre-cancers). The Whipple surgery is used to treat cancers and other pancreatic, intestinal and bile duct diseases. It is the most commonly utilized surgery to treat pancreatic cancer that has spread to the pancre.. View More»

    DOI: 10.35841/1590-8577- 23.11.776

    Abstract HTML PDF